Rainmed Medical Limited (2297.HK) HKSE
0.20
+0.001(+0.50%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.20
+0.001(+0.50%)
Currency In HKD
Sector
Healthcare
Industry
Medical - Devices
Employees
270
First IPO Date
July 08, 2022
| Name | Title | Pay | Year Born |
| Yonghui Lyu | Joint Chief Executive Officer | 1.83M | 1977 |
| Zeke Zhu | Joint Chief Executive Officer & Executive Director | 1.97M | 1985 |
| Jing Duan | Director for HR Department & Executive Director | 616,189 | 1985 |
| Yunfei Huo | Executive Chairman of the Board | 1.26M | 1979 |
| Liang Zhang | Joint Company Secretary | 1.96M | 1982 |
| Cheuk Ting Chu | Joint Company Secretary | 1.96M | 1980 |
| Chang Zhou | Vice President | 0 | 1978 |
| Xingyun Wu | Vice President | 0 | 1977 |
| Nina Cheng | International Marketing Manager | 0 | N/A |
| Guangzhi Liu | Chief Technology Officer | 0 | 1981 |
| Kangjian Liu | Vice President & Board Secretary | 0 | N/A |
Rainmed Medical Limited, a medical device company, focus on the design, development, and commercialization of coronary angiography-derived fractional flow reserve systems and coronary angiography-derived index of microvascular resistance systems. The company offers FlashAngio caFFR System, a coronary angiography-derived fractional flow reserve measurement system, which calculates FFR values based on a three-dimensional model of the coronary arterial system restored from two angiograms and FlashAngio caIMR System, a non-invasive microcirculatory lesion diagnosis and treatment system. It is also involved in developing intelligent angiographic injection, flash robot vascular intervention navigation operation system, and flash renal denervation systems. The company was founded in 2014 and is headquartered in Suzhou, China.